Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation

Transplant Infectious Disease

Volumn 12, Issue 3, 2010, Pages 251-257

  Leithauser, M ^a   Kahl, C ^a   Aepinus, C ^a   Prall, F ^a   Maruschke, M ^a   Riemer, H ^a   Wolff, D ^a   Jost, K ^a   Hilgendorf, I ^a   Freund, M ^a   Junghanss, C ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Allogeneic stem cell transplantation; Graft versus host disease; GVHD; Zygomycosis

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; CALCINEURIN INHIBITOR; CASPOFUNGIN; CIDOFOVIR; CYCLOSPORIN A; DACLIZUMAB; IMIPENEM; ITRACONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; PENTOSTATIN; POSACONAZOLE; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS; TEICOPLANIN; THYMOCYTE ANTIBODY; VORICONAZOLE; ANTIFUNGAL AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ADENOVIRUS INFECTION; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; DEBRIDEMENT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYPOKALEMIA; INVASIVE ZYGOMYCOSIS; KIDNEY; LUNG; LUNG ASPERGILLOSIS; LUNG INFILTRATE; MALE; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELOFIBROSIS; NUCLEOTIDE SEQUENCE; OSTEOMYELOFIBROSIS; PARANASAL SINUS; PRIORITY JOURNAL; PUVA; SKIN; SYSTEMIC MYCOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; ZYGOMYCETES; ZYGOMYCOSIS; ABSIDIA; ALLOTRANSPLANTATION; CLASSIFICATION; FATALITY; GENETICS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MUCORMYCOSIS; PATHOLOGY; RHIZOPUS; YOUNG ADULT;

ABSIDIA; ADULT; ANTIFUNGAL AGENTS; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS; RHIZOPUS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77953216860     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00480.x     Document Type: Article

References (31)

1. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003 102 (3) : 827 833. (Pubitemid 36917771)
2. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007 44 (4) : 531 540.
3. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002 34 (7) : 909 917. (Pubitemid 34229758)
4. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004 350 (9) : 950 952.
5. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006 25 (4) : 215 229.
6. Bretagne S, Costa JM, Marmorat-Khuong A, et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 1995 33 (5) : 1164 1168.
7. White TJ, Bruns T, Lee S, Taylor J. Amplification and sequencing of fungal ribosomal RNA genes for phylogenetics. In : Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR Protocols: A Guide to Methods and Applications., San Diego, CA: Academic Press Inc, 1990: 315-322.
8. Fujita SI, Senda Y, Nakaguchi S, Hashimoto T. Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains. J Clin Microbiol 2001 39 (10) : 3617 3622.
9. Maertens J, Demuynck H, Verbeken EK, et al. Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 1999 24 (3) : 307 312.
10. Herbrecht R, Letscher-Bru V, Bowden RA, et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001 20 (7) : 460 466.
11. Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004 39 (5) : 743 746.
12. Siwek GT, Dodgson KJ, Magalhaes-Silverman M, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004 39 (4) : 584 587.
13. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005 191 (8) : 1350 1360.
14. Shaukat A, Bakri F, Young P, et al. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia 2005 159 (2) : 181 188.
15. Kannan K, Ur-Rehman J, Rao TV, Jain R, Dennison D. Disseminated zygomycosis post allogeneic bone marrow transplantation. Am J Hematol 2005 79 (1) : 68 69.
16. Vigouroux S, Morin O, Moreau P, et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 2005 40 (4) : e35 e37.
17. Uckay I, Chalandon Y, Sartoretti P, et al. Invasive zygomycosis in transplant recipients. Clin Transplant 2007 21 (4) : 577 582.
18. Trifilio SM, Bennett CL, Yarnold PR, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007 39 (7) : 425 429.
19. Trifilio S, Singhal S, Williams S, et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007 40 (5) : 451 456.
20. Glockner A, Cornely OA. Zygomycosis after hematogeneic stem cell transplantation - a current problem? Med Klin (Munich) 2006 101 (9) : 724 729.
21. Mihu CN, King E, Yossepovitch O, et al. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis 2008 10 (3) : 162 167.
22. Sala-Torra O, Martin PJ, Storer B, et al. Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens. Bone Marrow Transplant 2008 41 (10) : 887 893.
23. Girmenia C, Moleti ML, Micozzi A, et al. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. J Clin Microbiol 2005 43 (10) : 5395 5396.
24. Safdar A, O'Brien S, Kouri IF. Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis. Bone Marrow Transplant 2004 34 (5) : 467 468.
25. Eisen DP, Robson J. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis. Mycoses 2004 47 (3-4) : 159 162.
26. Romano C, Ghilardi A, Massai L, Capecchi PL, Miraccco C, Fimiani M. Primary subcutaneous zygomycosis due to Rhizopus oryzae in a 71-year-old man with normal immune status. Mycoses 2007 50 (1) : 82 84.
27. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007 51 (7) : 2587 2590.
28. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006 50 (1) : 126 133.
29. van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006 42 (7) : e61 e65.
30. Rickerts V, Atta J, Herrmann S, et al. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia. Mycoses 2006 49 (Suppl 1) : 27 30.
31. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007 356 (4) : 335 347.